vs

Side-by-side financial comparison of BICYCLE THERAPEUTICS PLC (BCYC) and Himalaya Shipping Ltd. (HSHP). Click either name above to swap in a different company.

BICYCLE THERAPEUTICS PLC is the larger business by last-quarter revenue ($48.0M vs $29.9M, roughly 1.6× Himalaya Shipping Ltd.). Himalaya Shipping Ltd. runs the higher net margin — 3.7% vs -42.0%, a 45.7% gap on every dollar of revenue. On growth, BICYCLE THERAPEUTICS PLC posted the faster year-over-year revenue change (1193.3% vs -4.2%).

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical firm developing innovative bicyclic peptide therapies for unmet medical needs. Its core pipeline covers oncology, rare diseases, and immunological disorders, with operations in Europe and North America, and partnerships with global pharma leaders to advance drug candidates to market.

Himalaya Shipping Ltd. is a global maritime transportation enterprise focused on dry bulk shipping operations. It operates a fleet of modern, fuel-efficient bulk carriers that transport key commodities including iron ore, coal, grain and other bulk raw materials, serving core trade routes across Asia, Europe, and the Americas to support global industrial and agricultural supply chain flows.

BCYC vs HSHP — Head-to-Head

Bigger by revenue
BCYC
BCYC
1.6× larger
BCYC
$48.0M
$29.9M
HSHP
Growing faster (revenue YoY)
BCYC
BCYC
+1197.5% gap
BCYC
1193.3%
-4.2%
HSHP
Higher net margin
HSHP
HSHP
45.7% more per $
HSHP
3.7%
-42.0%
BCYC

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
BCYC
BCYC
HSHP
HSHP
Revenue
$48.0M
$29.9M
Net Profit
$-20.2M
$1.1M
Gross Margin
76.3%
Operating Margin
-51.5%
45.5%
Net Margin
-42.0%
3.7%
Revenue YoY
1193.3%
-4.2%
Net Profit YoY
61.1%
-84.1%
EPS (diluted)
$-0.29
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCYC
BCYC
HSHP
HSHP
Q4 25
$48.0M
Q3 25
$11.7M
Q2 25
$2.9M
$29.9M
Q1 25
$10.0M
Q4 24
$3.7M
Q3 24
$2.7M
Q2 24
$9.4M
$31.2M
Q1 24
$19.5M
Net Profit
BCYC
BCYC
HSHP
HSHP
Q4 25
$-20.2M
Q3 25
$-59.1M
Q2 25
$-79.0M
$1.1M
Q1 25
$-60.8M
Q4 24
Q3 24
$-50.8M
Q2 24
$-39.8M
$6.9M
Q1 24
$-26.6M
Gross Margin
BCYC
BCYC
HSHP
HSHP
Q4 25
Q3 25
Q2 25
76.3%
Q1 25
Q4 24
Q3 24
Q2 24
82.1%
Q1 24
Operating Margin
BCYC
BCYC
HSHP
HSHP
Q4 25
-51.5%
Q3 25
-558.6%
Q2 25
-2965.8%
45.5%
Q1 25
-703.7%
Q4 24
Q3 24
-2385.9%
Q2 24
-498.3%
56.1%
Q1 24
-162.4%
Net Margin
BCYC
BCYC
HSHP
HSHP
Q4 25
-42.0%
Q3 25
-503.7%
Q2 25
-2703.8%
3.7%
Q1 25
-608.9%
Q4 24
Q3 24
-1898.4%
Q2 24
-425.3%
22.1%
Q1 24
-136.0%
EPS (diluted)
BCYC
BCYC
HSHP
HSHP
Q4 25
$-0.29
Q3 25
$-0.85
Q2 25
$-1.14
$0.02
Q1 25
$-0.88
Q4 24
Q3 24
$-0.74
Q2 24
$-0.77
$0.16
Q1 24
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCYC
BCYC
HSHP
HSHP
Cash + ST InvestmentsLiquidity on hand
$628.1M
$24.7M
Total DebtLower is stronger
$701.3M
Stockholders' EquityBook value
$610.0M
$159.3M
Total Assets
$717.6M
$871.9M
Debt / EquityLower = less leverage
4.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCYC
BCYC
HSHP
HSHP
Q4 25
$628.1M
Q3 25
$648.3M
Q2 25
$721.5M
$24.7M
Q1 25
$793.0M
Q4 24
$879.5M
Q3 24
$890.9M
Q2 24
$961.4M
$21.9M
Q1 24
$457.0M
Total Debt
BCYC
BCYC
HSHP
HSHP
Q4 25
Q3 25
Q2 25
$701.3M
Q1 25
Q4 24
Q3 24
Q2 24
$30.9M
$725.5M
Q1 24
$30.8M
Stockholders' Equity
BCYC
BCYC
HSHP
HSHP
Q4 25
$610.0M
Q3 25
$618.5M
Q2 25
$668.9M
$159.3M
Q1 25
$740.3M
Q4 24
$793.1M
Q3 24
$831.0M
Q2 24
$873.8M
$157.2M
Q1 24
$356.0M
Total Assets
BCYC
BCYC
HSHP
HSHP
Q4 25
$717.6M
Q3 25
$764.0M
Q2 25
$832.2M
$871.9M
Q1 25
$883.9M
Q4 24
$956.9M
Q3 24
$996.7M
Q2 24
$1.1B
$897.3M
Q1 24
$547.1M
Debt / Equity
BCYC
BCYC
HSHP
HSHP
Q4 25
Q3 25
Q2 25
4.40×
Q1 25
Q4 24
Q3 24
Q2 24
0.04×
4.61×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCYC
BCYC
HSHP
HSHP
Operating Cash FlowLast quarter
$-19.3M
$8.3M
Free Cash FlowOCF − Capex
$-19.9M
FCF MarginFCF / Revenue
-41.5%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
7.55×
TTM Free Cash FlowTrailing 4 quarters
$-252.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCYC
BCYC
HSHP
HSHP
Q4 25
$-19.3M
Q3 25
$-71.2M
Q2 25
$-72.8M
$8.3M
Q1 25
$-86.4M
Q4 24
$-164.7M
Q3 24
$-39.8M
Q2 24
$-44.6M
$17.6M
Q1 24
$-70.9M
Free Cash Flow
BCYC
BCYC
HSHP
HSHP
Q4 25
$-19.9M
Q3 25
$-71.8M
Q2 25
$-73.3M
Q1 25
$-87.0M
Q4 24
$-166.0M
Q3 24
$-40.3M
Q2 24
$-45.0M
Q1 24
$-70.9M
FCF Margin
BCYC
BCYC
HSHP
HSHP
Q4 25
-41.5%
Q3 25
-612.3%
Q2 25
-2509.7%
Q1 25
-871.7%
Q4 24
-4475.7%
Q3 24
-1504.7%
Q2 24
-481.2%
Q1 24
-362.9%
Capex Intensity
BCYC
BCYC
HSHP
HSHP
Q4 25
1.2%
Q3 25
5.7%
Q2 25
17.1%
Q1 25
6.1%
Q4 24
33.3%
Q3 24
16.3%
Q2 24
4.5%
Q1 24
0.1%
Cash Conversion
BCYC
BCYC
HSHP
HSHP
Q4 25
Q3 25
Q2 25
7.55×
Q1 25
Q4 24
Q3 24
Q2 24
2.55×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons